Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

Glaxo Wellcome presents development candidate GW-311616A

Aug. 27, 1998

P&G claims alpha2-adrenoceptor agonists with a wide range of potential applications

Aug. 27, 1998

Novel antiinflammatory/antiallergy agents in the pipeline at Japan Energy

Aug. 27, 1998

Antiasthma drug candidate enters phase I testing at Pharmacia & Upjohn

Aug. 25, 1998

Pfizer selects LTB4 antagonist for clinical testing

Aug. 25, 1998

Japanese lab describes new agents for asthma and inflammation

Aug. 25, 1998

Sankyo describes NK1/NK2 antagonists for treating asthma

Aug. 25, 1998

First European filing for TOBI

Aug. 24, 1998

Tanabe Seiyaku team identifies new candidates for asthma

Aug. 21, 1998

More PDE4 inhibitors described by Byk Gulden

Aug. 20, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...